Lipopolysaccharide (LPS) causes endothelial cell injury both in vitro and in vivo. It is widely believed that this injury in vivo enhances the transport of macromolecules from plasma into the interstitial space of the underlying artery wall. A new technique was used in rats to obtain high resolution transmural profiles of macromolecules in vivo. We compared the time course of the macromolecular transport into the aortic tissue in vivo after LPS injection to that of LPS-induced endothelial cell death and the proliferative response of the endothelium to LPS injury. At a dose of 1 mg LPS/kg body wt, endothelial cell death reached a maximum by 36 hours after LPS injection and remained elevated for 96 hours; the peak of the S phase of endothelial cell proliferation was observed 48 hours after injection. To examine the effect of LPS on macromolecular accumulation, we measured aortic intimal and medial transmural concentration profiles of horseradish peroxidase (HRP) after circulation of HRP for 15 minutes. The data revealed a transient increase in total aortic accumulation (reflecting predominantly the media), which was maximal between 12 and 48 hours after LPS injection. Although total medial accumulation was found to return to near control levels by 72 hours after LPS injection, intimal accumulation remained elevated above control levels for 120 hours. When HRP was added to the perfusate of an in situ aorta preparation at a near zero transmural pressure gradient, the resulting transmural concentration profiles across aortas from control rats and from rats given LPS 24 hours previously were indistinguishable, whereas a pressure gradient of 60 mm Hg revealed LPS-altered concentration profiles analogous to those in vivo. This suggests that the accumulation of HRP observed in vivo was driven by increased convective transport. These results reveal that LPS enhances entry of macromolecules into the aorta wall in vivo. The changes in macromolecular transport do not, however, correlate temporally with endothelial cell death or proliferation. The results are consistent with an LPS-induced decrease in the endothelial barrier function, which precedes, and may be independent of, cell death and a transient increase in convective transport across the media due to alterations in the barrier function of the internal elastic lamina. (Circulation Research 1991;68:1259-1269 It has been proposed that a breach in the integrity of the endothelial cell layer results in an increased transport and accumulation of plasma macromolecules in the underlying arterial wall.12 Endothelial cell injury has been proposed as an early event in atherosclerosis.3 A version of this endothelial injury hypothesis proposes that the process of endothelial regeneration in response to injury com-promises the barrier function of this cell layer and allows lipoproteins and other plasma macromolecules to enter the intimal layer more easily.24 This intriguing idea has proven difficult to test experimentally, although Lin et a15 recently demonstrated that areas of increased accumulation of lucifer yellowlabeled low density lipoprotein were associated with mitotic figures in the endothelium of the rat aorta. Lipopolysaccharide (LPS) has been shown in vitro and in vivo to cause endothelial cell death.6-13 The endothelial response to LPS injury ultimately includes focal cell death and an increase in local endothelial cell proliferation.8 It also has been shown that the proliferative response of endothelium to LPS injury is transient and concentration dependent.6'9"10 Reidy and Schwartz9 have shown by scanning electron microscopy that, at certain LPS concentrations,
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To determine whether LPS-induced changes increased arterial transport of plasma-borne macromolecules, we used a recently developed technique to measure intimal and medial accumulation of horseradish peroxidase (HRP) in vivo after 15 minutes of HRP circulation in plasma as a function of time after LPS injection.14 To examine whether the effect of endotoxin was related to its cytotoxic effects or to the subsequent endothelial repair process, we also measured the time course of endothelial cell death and proliferation.
Materials and Methods

Characterization of the LPS Injury Model
To relate the extent and time course of the LPSinduced injury to aortic transport changes, we characterized the injury by measuring endothelial cell death and proliferation, indexes that have been used previously by others to quantify LPS injury to aortic endothelium in vivo.913,15 Dead endothelial cells of rats were visualized by immunohistochemically staining cells that had accumulated immunoglobulin G (IgG). Cytoplasmic IgG has been demonstrated to be a reliable marker of cell death. 15 The nuclei of proliferating endothelial cells that had incorporated ['H]thymidine into DNA were visualized autoradiographically. Both visual signals were quantified by trained observers counting the number of positive cells in coded endothelial monolayer preparations from the descending thoracic aortas. Injection of LPS. LPS (Salmonella typhosa, Sigma Chemical Co., St. Louis) was added to phosphate buffered saline (PBS) at a concentration such that 100 ,l would deliver the desired dose to a 350-g rat. Sonication was used to promote dissolution or uniform dispersion. LPS was injected into the tail vein of ether-anesthetized rats over a 15-20-second period. The volume injected was proportional to the body weight of each rat.
Dose-response and time course. To determine doses at which various endothelial responses could be observed, groups of two to five male Sprague-Dawley rats each received injections of 0.0, 0.0001, 0.001, 0.01, 0.1, 1.0, or 8.0 mg LPS/kg body wt 72 hours before they were killed. To determine the time course of endothelial cell injury, groups of three to six male Sprague-Dawley rats were injected with either 0.5 or 1.0 mg LPS/kg. Rats receiving 1.0 mg LPS/kg were killed after LPS circulation times of 6, 12, 18, 24, 36, 48, 72, 96 , and 120 hours, and those receiving 0.5 mg LPS/kg were killed 6, 18, 24, 30, and 48 hours after LPS injection. A "0-hour" group received no injection. As additional control animals, pairs of male Sprague-Dawley rats were injected with 100 ,ul PBS/350 g body wt and killed at 24, 48, 72, and 96 hours after injection. Four hours before death, all rats were injected with [3H]thymidine (500 ,tCi/kg body wt i.p., ICN ImmunoBiologicals, Lisle, Ill.). Endothelial cell proliferation and/or endothelial cell death was assessed for the aorta of each rat.
Sampling of the thoracic aorta. At the indicated time, the rat was anesthetized by intraperitoneal sodium pentobarbital (50 mg/kg), and 3-5 ml blood was removed via the iliac artery bifurcation. The thoracic cavity was opened, and 3 ml PBS at room temperature was injected into the left ventricle, followed by 10 ml phosphate buffered formalin at room temperature. The descending thoracic aorta was allowed to fix in situ for 5-10 minutes, after which it was removed and submerged in formalin. The thoracic aorta distal to the upper pair of intercostal arteries was divided into thirds. The middle third was left in the buffered formalin overnight before processing for the autoradiographic assessment of [3H]thymidine incorporation; the distal third was removed after 30 minutes and placed in distilled water for immunohistochemical processing for cytoplasmic IgG accumulation.
Endothelial Cell Proliferation and Autoradiography
The middle third of the thoracic aorta was sectioned longitudinally between each pair of intercostal ostea, pinned open, endothelial side up, on dental wax, rinsed in running water for a minimum of 4 hours, and dehydrated in sequential solutions of increasing ethyl alcohol content (50%, 70%, 95%, and two changes of 100%) at 20-minute intervals. The final incubation in 100% ethanol was continued overnight under vacuum before remaining monolayers of aortic endothelial cells were made (Hautchen preparations) using a modification of the method of Hirsch et al. 16 The adventitia was gently peeled away, the remaining tissue was briefly dipped in acetone, and visible liquid was removed. The endothelial surface was pressed against the exposed surface of a piece of two-sided tape on a microscope slide. The adhered tissue was dried with a stream of compressed air. The tissue was covered with a bubble of 30% H202 for 1 minute, submerged briefly in distilled water, and covered with H202 for an additional minute. The media was then removed from the adherent endothelial layer by pulling it back with a pair of forceps. To assess endothelial cell proliferation, [3H]thymidine incorporation into DNA was visualized on slides containing endothelial monolayers, coated with photographic emulsion (Ilford K5.D, Polysciences Inc., Warrington, Pa.) and exposed for 2-3 weeks at -20°C. The developed slides were rinsed in distilled water, and endothelial cell nuclei were counterstained with a 1:5 dilution of Mayer's hematoxylin (Poly Scientific, Bay Shore, N.Y.) in distilled water for 1 minute. The nuclei were intentionally stained lightly to avoid ambiguity between the nuclear stain and the silver grains that developed in the emulsion over the nuclei of cells in S phase.
Endothelial Cell Death
Cytoplasmic accumulation of IgG was visualized immunohistochemically within endothelial cells from the distal third of the descending thoracic aorta by our modification of the method of Hansson and Schwartz.15 The tissue was first sectioned longitudinally between each pair of intercostal ostea. Unreacted formalin was rinsed from the tissue using at least four changes of 10 ml distilled water at room temperature with at least 1 hour between changes. Intracellular IgG accumulation was detected by an anti-rat IgG immunostain kit (Vectastain, Vector Laboratories, Inc., Burlingame, Calif.). The tissue was incubated in a solution of biotinylated anti-rat IgG for 30 minutes, rinsed in three changes of PBS (10 minutes between changes), incubated with an alkaline phosphatase-labeled avidin-biotin complex for 30 minutes, and rinsed in three changes of PBS (10 minutes between changes). Bound alkaline phosphatase was visualized by incubating the tissue for 30 minutes in Vector-Red substrate (Vector Laboratories). The tissue was pinned open, endothelial side up, on a piece of dental wax and dehydrated in sequential solutions of increasing ethyl alcohol content (50%, 70%, 95%) at 20-minute intervals before endothelial monolayers were prepared.
Quantifying the Number of Labeled Cells or Nuclei.
The number of labeled cells (cell death) or nuclei (cell proliferation) from the thoracic aorta endothelial layers were counted by using a microscope (Carl Zeiss, Thornwood, N.Y.) with a x25 objective lens and a x 12.5 eyepiece. Five fields, containing approximately 750 endothelial cells each, were counted on each endothelial monolayer. Care was taken to match the aortic sites examined for each rat. 17 To accomplish this, the five fields chosen were along a line in the longitudinal direction, approximately equidistant from the intercostals on the middle third (cell proliferation) or distal third (cell death) of the descending thoracic aorta. Counting was performed by two or three independent, trained observers who were blinded to the experimental groups of the slides.
Effect of LPS-Induced Endothelial Injury on Transmural HRP Profiles as a Function of Time After Injuty
To evaluate the effect of endotoxin-induced endothelial cell death and proliferation on arterial macromolecular transport, we measured transmural HRP concentration profiles as a function of time after LPS injection.14 Twenty-one male Sprague-Dawley rats (350-400 g) were divided into seven groups and injected via the tail vein with 1.0 mg LPS/kg body wt as described above. A 0-hour group received no injection; in the other six groups, the rats were terminated at 12, 24, 36, 48, 72, or 120 hours after LPS injection.
HRP was prepared and iodinated with Na"1I using the iodinating agent 1,3,4,6-tetrachloro-3a,6a-diphenylglycouril (lodogen, coated on the inside of glass test tubes, or lodo-beads, Pierce Chemical Co., Rockford, Ill.) as described by Penn et al.14 HRP concentration profiles were obtained as described by Penn et al.14 The rats were anesthetized with sodium pentobarbital (50 mg/kg i.p.) and injected with 50 mg HRP/kg via an exposed femoral vein. This dose of HRP was chosen because Huttner et al18 demonstrated that a 100 mg/kg dose of HRP did not result in the depression of the blood pressure in Sprague-Dawley rats 6 minutes after injection and because Backwinkel et al19 found no histological evidence in rabbit coronary arteries that a 300 mg/kg dose of HRP caused changes that could have affected HRP transport, such as inflammation, release of vasoactive amines, or antigen-antibody reactions. Therefore, we believe that the HRP concentration profiles measured in these studies reflect HRP transport processes that are unperturbed by the presence of HRP. The injection volume was approximately 0.5 ml. The HRP was allowed to circulate for 15 minutes. This circulation time was chosen from preliminary experiments that revealed that HRP reaction product was readily detectable in the central media by 15 minutes. Longer circulation times were avoided to minimize the effects of the exponential decrease in plasma HRP concentration (see below).
During the final 45 seconds, 3-5 ml blood was removed via the iliac artery bifurcation and drawn into a sterile tube containing liquid EDTA. Unbound 125j in the final plasma samples was found to be negligible by assaying for 'I with Centricon filters (Amicon, Danvers, Mass.). Final plasma HRP concentration was determined by assaying this sample for [1251]HRP. At the end of the circulation time, the thoracic cavity was opened and 1-3 ml ice-cold PBS was injected into the left ventricle, followed by 10 ml ice-cold 2.5% glutaraldehyde in PBS. After 5-8 minutes, the thoracic aorta was removed, and ringshaped aortic samples were processed as detailed by Penn et al.'4 An HRP standard curve was prepared as previously described by equilibrating fresh aorta samples from rats not receiving HRP with solutions of known HRP concentration before fixation.'4 The tissues for the standard curve were reacted with substrate (3,3'-diaminobenzidine and H202) along with tissue from the experimental rats. The standard curve was used to convert relative gray scale (RGS) values obtained from the image processing (see below) to HRP concentrations.
The reaction product of HRP standards was measured in aortic sections from experimental animals as a RGS value on an IBAS II image processing system (Carl Zeiss).14 The transmural HRP concentration profiles were obtained from the RGS of a series of rectangles delineating equal volumes of tissue from lumen to adventitia; therefore, they represent the HRP concentration along a radial line orthogonal to the endothelial plane. All HRP RGS data were the averages of 12 randomly chosen profiles per rat (four profiles from each of three samples of aorta). The elastin layers of each tissue section were delineated by the operator and, for these experiments, were excluded from the data pool. Thus, the data from elastin layers that do not contain HRP reaction product were not included in the average RGS values. 19 We showed previously that 0.32 of the tissue volume is available to HRP when measured in equivalents of the bulk phase concentration equilibrated with the tissue.14 The value of the volume fraction of the rat aortic tissue accessible to HRP not including the volume of tissue occupied by elastin was calculated to be 0.375, and this value was used in the present study for the conversion from HRP concentration in the equilibrating solution to HRP concentration expressed per gram of wet tissue. With this relation, we obtained a standard curve relating RGS to milligrams of HRP per gram wet tissue. Using this standard curve, RGS values measured in experimental rats were converted to milligrams of HRP per gram wet tissue. This concentration was then normalized by the initial plasma HRP concentration in each rat (see below) to facilitate comparison of the concentration profile in one rat to that in another. Transmural HRP accumulation was determined by integrating the transmural concentration profiles using the trapezoidal approximation.
The plasma HRP concentration was determined by measuring [1251]HRP in plasma and the initial injection solution; plasma concentration of HRP was determined by dividing the plasma concentration of 125I by the specific activity of the HRP injected. Disappearance of HRP From Plasma Before injecting HRP, the contralateral femoral artery was exposed in selected rats to determine the time constant of HRP disappearance from the plasma. The artery was nicked, and a blood sample was taken in a 44.7-,l heparinized micropipette to determine the hematocrit. The hematocrit was used to determine what fraction of the subsequent blood samples represented plasma. It has been shown and we confirmed that LPS injection does not affect the hematocrit. 20 The rat was then injected with HRP as described above. Up to four blood samples were taken using these micropipettes at various times up to 15 minutes after injection. The samples were added to 1 ml PBS and spun at 2,000g. A 100-,ul sample was taken from the supernatant and assayed for 1251 in a gamma counter. The amount of unbound 1251 from a 100-,A sample was determined to be negligible by assaying the 1251 flowing through a Centricon filter (10,000-Da limit, Amicon).
Measurement of Transmural HRP Concentration Profiles in an In Situ Preparation With and Without a Transmural Pressure Gradient
We wished to determine if the altered transmural HRP transport we observed after LPS injection was due to increased convective transport, that is, the movement of HRP due to fluid drag driven by the transmural pressure gradient. Therefore, we measured transmural concentration profiles in an in situ aortic preparation in which we could control the transmural pressure gradient. In this preparation, we could determine if a convective driving force was necessary for the altered transmural HRP concentration profiles we observed.
In the in situ preparation, HRP was introduced to the thoracic aorta retrograde. Twelve male Sprague-Dawley rats (350-400 g) were divided into two equal groups. One group received an injection of 1 mg LPS/kg 24 hours before the experimental procedure, and the other group served as controls and received no injection. After induction of anesthesia using sodium pentobarbital (50 mg/kg i.p.), the abdominal cavity was opened. The abdominal aorta was exposed from the iliac bifurcation to the renal arteries and cannulated above the iliac bifurcation with Tefloncoated tubing filled with heparin (1,000 USP units/ ml) and connected to a 1-ml syringe. The cannula was extended a previously marked distance and secured with nylon thread, so that it was immediately distal to the diaphragm in the abdominal aorta. Blood was drawn into the syringe, mixed with the heparin, and pushed back through the cannula. The cannula was then connected to a reservoir containing cell culture medium (a mixture of Dulbecco's Modified Eagle Medium and Ham's F-12 [1 :11 with 15 mM HEPES and L-glutamine, GIBCO Laboratories, Grand Island, N.Y.) at 37°C. The cell culture medium was under sufficient pressure so that, when the aortic arch was cannulated, the thoracic aorta did not collapse. The thoracic cavity was opened, and the aortic arch was carefully cannulated to serve as an effluent. The temperature of the exposed thoracic cavity was maintained at 36.5-37.5°C by means of an incandescent lamp. The aortic arch cannula extended approximately 0.5 cm into the vessel and was secured with nylon thread; the cell culture medium was allowed to flow retrograde through the descending thoracic aorta. The time between beginning surgery and obtaining perfusion through the aorta was 8-12 minutes. Medium was allowed to flow retrograde for approximately 1-2 minutes, at which time the cannula was switched to a reservoir containing the 1 mg HRP/ml cell culture medium for 15 minutes as outlined below.
Three rats from each of the above two groups were perfused with HRP using a minimal transmural pressure gradient; the effluent cannula was allowed to remain open. The average flow rate through the thoracic aorta was 53.0 ml/hr. The transmural pressure gradient was determined to be <5 mm Hg by measuring the height of water in a manometer placed at the exit of tubing that was identical in length and type to that used to cannulate the abdominal aorta.
Flow was sufficient to prevent the thoracic aorta from collapsing during the perfusion.
The other three rats from each group were exposed to a 60 mm Hg transmural pressure gradient; the HRP solution was introduced through the can- nula for 15 seconds by a compressed air perfusion pump. The effluent was then clamped, and the pressure was monitored by a force-pressure transducer joined by a T-shaped connector with the abdominal aorta cannula. The pressure transducer was connected to the T-shaped connector by tubing identical in type and approximately equal in length to that used to cannulate the abdominal aorta. The pressure transducer output was calibrated using a sphygmomanometer and monitored on a strip-chart recorder. The transmural pressure gradient was maintained for 15 minutes at 60 mm Hg at the entrance to the abdominal aorta by manually pumping air into the 60 -40 -20 0 compression chamber. After the 15-minute period of HRP exposure, ice-cold 2.5% glutaraldehyde in PBS was introduced. From this point, the tissue was treated as described above for the in vivo case. A standard curve was prepared from aortas not exposed to HRP in vivo or in situ but equilibrated with known HRP solutions in vitro as described above. Tissues used to construct the standard curve were reacted with the 3,3'-diaminobenzidine and H202 as the experimental tissues (see above).
Results
Endothelial Cell Death and Proliferation as a Function of LPS Dose Figure 1 shows that at 72 hours after LPS injection, endothelial cell turnover was significantly greater than control at a dose of 0.001 mg LPS/kg. At 1.0 mg/kg, a marked increase occurred in which the number of proliferating cells was 25-fold higher than in control rats.
Endothelial Cell Death and Proliferation as a Function of Time After LPS Injection
We observed a transient increase in endothelial cell death that reached a peak 36 hours after injection of 1.0 mg LPS/kg and remained elevated through 96 hours (Figure 2, left panel) . There was no statistically significant increase in cell death before 36 hours; by 120 hours, the number of dead endothelial cells decreased but was still greater than control. The peak in endothelial cell death was followed by a peak in endothelial cell proliferation. Endothelial cell proliferation, expressed as an index of the number of cells in S phase, reached a maximum 48 hours after LPS injection for a 1.0 mg LPS/kg dose (Figure 2 Figure 3 . The solid line is the least-squares fit using the single exponential function to represent the disappearance of labeled HRP from the plasma. The model fit yields a time constant for HRP disappearance in plasma of 17.5 minutes, which has an equivalent half-life of 12.1 minutes. There was no significant difference in the time constant measured in control rats and that in LPS-treated rats. The time constant was used in conjunction with the concentration of HRP determined in the final plasma sample to determine the initial plasma HRP concentration (i.e., at the time of injection, t=0) for each rat. Normalization of the data by the initial plasma HRP concentration was used to facilitate comparisons among rats.
Altered Transmural HRP Concentration Profiles as a
Function of Radial Distance Into Arterial Wall Measured In Vivo (1.0 mg LPS/kg) Figure 4 , left panel, depicts an HRP-stained cross section, such as those described in "Materials amd Methods," from a rat that did not receive LPS. The concentration of HRP is greatest near the lumen and gradually decreases further into the intima. Figure 4 , right panel, depicts a similarly treated cross section from a rat that received 1.0 mg LPS/kg 24 hours before death. In contrast to the uninjured vessel, the HRP concentration in this cross section is not clearly maximal near the lumen; rather, HRP has accumulated in significant concentrations into the third medial layer. Figure 5 compares the average relative concentration profile of three uninjected rats with that of three rats 24 hours after injection of 1.0 mg LPS/kg. These data show that the increased HRP accumulation was due to marked increases in the luminal portion of the media of the arterial wall. The intima was typically 0-0.025 in the normalized units of distance depicted in Figure 5 . 
Intimal and Transmural HRP Accumulation as a Function of Time After 1.0 mg LPS/kg Injection
The time course of the average intimal HRP accumulation of each group of three rats shows a significant increase over control (time 0) 24-120 hours after LPS injection ( Figure 6, left panel) . The data indicate a monotonically increasing trend in intimal accumulation over time. Microscopic examination of the intima at the sites at which the HRP measurements were made indicated that the HRP accumulation was localized to the fluid space of the intima and not due to its presence within endothelial cells or smooth muscle cells. The average transmural HRP accumulation (predominantly in the media) measured in each group of three rats was increased at 12 hours and reached a maximum 24 hours after LPS injection ( Figure 6, right panel) . At 36 and 48 hours, transmural HRP accumulation successively decreased but remained elevated above control. At 72 and 120 hours, accumulation was only slightly elevated above control. The injection of PBS alone did not result in altered HRP accumulation (data not shown). Transmural HRP Concentration Profiles as a Function of Radial Distance Into Arterial Wall Measured In Situ With and Without a Transmural Pressure Gradient
The transmural pressure gradient is the driving force for convective transport; therefore, by removing it, we could determine the importance of convection to the altered macromolecular transport observed in vivo after LPS injection. In these experiments, the aortas were cannulated in uninjected rats or at 24 hours after injection of 1.0 mg LPS/kg, and perfusate was introduced at controlled pressure levels. When the transmural pressure gradient was maintained at <5 mm Hg, there was no significant difference between the uninjected and LPS-injected groups (Figure 7, right panel) . However, an altered concentration profile qualitatively similar to that measured in vivo was observed in three uninjected rats and in rats 24 hours after LPS injection when a 60 mm Hg transmural pressure gradient was applied in situ (Figure 7 , left panel).
Altered Transmural HRP Concentration Profiles
Measured In Vivo 24 Hours After 0.0001 mg LPS/kg The lack of a temporal coincidence between cell death, cell proliferation, and increased transport relative transmural (predominantly medial) HRP accumulation in aortic wall as a function of time after injection of 1 mg LPSIkg body wt. Total accumulation was determined by integrating the appropriate transmural concentration profiles by the trapezoidal rule. Accumulation is expressed relative to Cpo. Twelve transmural concentration profiles (fourprofiles from each of three sections) were measured in each aorta. Error bars represent the standard error of the mean of the values from three rats at each time point.
Values at 12, 24, 36, and 48 hours are statistically greater than control (p<0.05). Graph showing relative transmural HRP concentration profile as a function of radial distance from the endothelium measured in situ with a 60 mm Hg transmural pressure gradient in uninjected rats (open circles) and in rats injected with 1 mg LPS/kg body wt 24 hours before termination (filled circles). Twelve transmural concentration profiles (fourprofilesfrom each ofthree sections) were measured in each aorta. Error bars represent standard error of the mean of three rats per group.
suggested that increased transport could occur without LPS-induced cell death. Therefore, we examined concentration profiles of HRP 24 hours after an LPS dose of 0.0001 mg/kg, a dose at which no detectable increase in endothelial cell proliferation occurs. Figure 8 compares the average relative concentration profile of three uninjected rats with that of three rats 24 hours after injection of 0.0001 mg LPS/kg body wt. These data show that increased HRP accumulation occurred due to marked increases in the luminal portion of the media of the arterial wall. . Ct, tissue HRP concentration; Cpo, plasma HRP concentration at the time of injection. Twelve transmural concentration profiles (fourprofiles from each of three sections) were measured in each aorta. Error bars represent standard error of the mean of three rats per group.
Discussion
Characterization of LPS-Induced Endothelial Cell Death and Proliferation
Our data demonstrate that an intravenous injection of LPS into the rat results in doseand time-dependent cytotoxic and proliferative endothelial cell response, as well as altered macromolecular transport of plasma-borne macromolecules into the arterial wall. The relative time courses of endothelial cell death (maximal at 36 hours, Figure 2 , left panel) and proliferation (maximal at 48 hours, Figure 2 , right panel) are consistent with the idea that the endothelial cell proliferation seen after LPS injection is in response to endothelial cell death.9 Since the method we used measures all adherent dead endothelial cells present at the time of death of the rat, a cell that died 36 hours after LPS injection would still be visualized 48 hours after LPS injection if it remained attached to the vessel wall. Thus, the sustained endothelial cell death through 96 hours could reflect either continued endothelial cell death through 96 hours or endothelial cells that died between 24 and 36 hours and remained attached to the vessel wall through 96 hours.
Correlation of LPS-Induced Endothelial Cell Injury With Changes in Transmural Macromolecular Accumulation
We asked whether the LPS-induced endothelial cell death and proliferation described above would result in altered macromolecular transport into and across the arterial wall. It was proposed previously that the loss and reformation of endothelial cell gap junctions during proliferation result in increased macromolecular permeability.5,21-25 Using a method we previously developed, we allowed HRP to circulate for 15 minutes and measured the resulting 14 We observed steadily increasing HRP levels in the intima for 120 hours after LPS injection ( Figure 6 , left panel). The HRP concentration present in the fluid space of the intima (i.e., tissue water space concentration corrected to reflect the HRP in the space available to it, assuming the porosity of the intima to be equal to that of the media, 0.375) normalized by the final plasma HRP concentration is equal to 0.38 in uninjected (uninjured) rats and 0.58, 0.73, 0.82, and 0.97 in injected rats at 24, 48, 72, and 120 hours after LPS injection, respectively. The approach of these values to 1.0 indicates the progressive ease in which equilibration between HRP in plasma and intimal interstitial fluid occurred during the 15-minute circulation of HRP. The steady rise in intimal accumulation over time after LPS injection is not necessarily indicative of increasing endothelial permeability but rather may reflect that at earlier times HRP was able to more freely enter the media ( Figure 6 , right panel), thereby delaying equilibration between the intima and the plasma. These data also demonstrate the inability of the endothelium to act as a barrier to macromolecular entry even when the repair process, as monitored by endothelial cell proliferation (Figure 2 , right panel) is near completion.
In contrast to intimal levels, medial HRP accumulation was maximal between 12 and 48 hours after LPS injection and returned to control levels by 72 hours (Figure 6, right panel) . This time course indicates that the altered transport preceded endothelial cell death and maximal proliferation (Figure 2) . The transient increase in medial HRP accumulation suggests among other alternatives (see below) that the internal elastic lamina (IEL) also acts as a major barrier to protein entry as proposed by Fry' and Smith and Staples26 and that the IEL is affected by LPS. There is previous evidence of an effect of LPS on the IEL. Lee et a127 demonstrated that an LPS injection into rats caused transient morphological changes in the IEL. The changes they observed occurred at <4 hours after LPS exposure. It is unclear from their data whether other parameters of IEL morphology, such as the degree of IEL fenestration, which could have profound effects on the barrier function of the IEL, were altered by LPS injection.
Speculations concerning the driving forces responsible for increased transmural HRP accumulation observed after endothelial injury by LPS can be made by comparing the shapes of the transmural concentration profiles across injured and uninjured aortas ( Figure 5 ). The average transmural concentration profile measured in the control group was diffusive in form and qualitatively comparable with the diffusive profiles for labeled lipoproteins, albumin, and HRP measured in normal aortas from several species.1428-31 The altered transport was characterized by a nondiffusive profile in which successive data points from the endothelium did not decrease monotonically. Two mechanisms could result in such al-tered transmural concentration profiles. First, LPS injury could result in an increased interstitial distribution space for macromolecules in the innermost medial layers. HRP accumulating in such an "edematous" tissue could explain the observed changes in the transmural concentration profiles. A second possibility is that a loss in not only endothelial but also IEL integrity due to LPS allowed increased convective transport of water and solutes into and across the aortic wall. Convective transport through the arterial wall includes the movement of macromolecules across the intima and media due to the drag of the pressure-driven fluid movement.32 It has been demonstrated with mathematical simulations that increased convective transport can result in altered transmural concentration profiles qualitatively similar to those we observed after LPS injury. 28, 29, 33 To distinguish between these two mechanisms, we measured transmural HRP concentration profiles in situ in an aortic preparation in which we could control the transmural pressure gradient. The data from these experiments demonstrate that, when the transmural pressure gradient (i.e., the driving force for convective transport) was minimized, there was no difference between the transmural concentration profiles measured in uninjected rats and in those injected 24 hours previously with LPS (Figure 7 , left panel), whereas the imposition of a 60 mm Hg transmural pressure gradient resulted in an altered transmural HRP concentration profile only in those rats injected with LPS 24 hours previously (Figure 7 , right panel). The absence of an altered profile in preparations that lacked a transmural pressure gradient suggests that increased transmural convective transport rather than altered distribution space resulted in the altered HRP transport observed in vivo.
Our finding that LPS causes a transient increase in convective transport in vivo is qualitatively consistent with the finding of Meyrick et al,6 who observed that the addition of LPS to a bovine pulmonary endothelial cell monolayer in vitro resulted in increased hydraulic conductivity 1 hour later and increased permeability to [125T]albumin 3 hours later. However, because of the inherent difficulties involved in interpreting endothelial monolayer transport studies, it was not clear whether the LPS-induced increase in macromolecular transport was due to altered barrier function of the endothelial monolayer without cell loss or to the detachment of dead or dying endothelial cells from the substrate surface. 34 Tedgui and Lever35 demonstrated that denuding the rabbit aorta with a balloon catheter resulted in increased hydraulic conductivity across the arterial wall in situ. They proposed that an intact endothelial layer acts to minimize the effect of the transmural pressure gradient on fluid movement into the vessel wall. As discussed above, however, the transient increase we observed in medial accumulation is likely due to transient changes in the barrier function of the IEL; our data indicate that it is the IEL, not the endothelium, that acts to minimize convective trans-port across the arterial wall. A possible explanation for this apparent discrepancy is that the IEL in the denuded aortas studied by Tedgui and Lever35 was also damaged by the balloon catheter, which has been shown by others to injure the medial layers near the lumen.36
Effect of a Subtoxic Dose of LPS on Macromolecular Entry
We wanted to determine if an injection of LPS at a dose that did not lead to endothelial cell proliferation would result in increased HRP entry into the arterial wall. We measured transmural concentration profiles in rats that were injected with 0.0001 mg LPS/kg body wt 24 hours previously. This dose did not cause increased endothelial cell proliferation 48 hours (data not shown) or 72 hours (Figure 1 ) after injection but caused a significant increase in protein entry into the arterial wall ( Figure 8 ). This profile is not altered to the same extent as that seen in Figure  5 or the right panel of Figure 7 , which may indicate that the barrier function of the endothelium plus IEL is not altered to the same extent at this dose as it is at 1 mg LPS/kg.
The increased protein entry observed after the 0.0001 mg LPS/kg dose implicates two possible mechanisms by which LPS results in increased endothelial cell permeability. The first is that focal regions of endothelial cell death cause a loss in the endothelial cell barrier function. For the 0.0001 mg LPS/kg dose, repair of any endothelial cell death could be by the migration of neighboring endothelial cells, not endothelial cell proliferation,37 since we have no evidence of significant endothelial cell proliferation in response to this LPS dose (Figure 1 ). However, for the 1.0 mg LPS/kg dose, it is clear that the extent of the LPS-induced endothelial cell death requires a significant proliferative response to repair (Figure 2 , right panel). Thus, for this possibility, both the high and low doses of LPS cause endothelial cell death, which results in increased protein entry.
A second explanation is that the 0.0001 mg LPS/kg dose increased endothelial cell permeability without cell death. This would take place by a change in endothelial cell function through an effector mechanism induced by LPS, such as the LPS-stimulated release of tumor necrosis factor (TNF). It has been demonstrated in vitro by others that TNF causes cytoskeletal changes in endothelial cells; these changes compromise the barrier function of the endothelium.3839 TNF has also been shown to increase pulmonary vascular permeability.40 Although we did not measure circulating TNF levels in these experiments, it is known that LPS results in a transient increase in TNF mRNA41 and circulating TNF levels.42,43 Alterations in endothelial cell cytoskeleton due to increases in circulating TNF could explain both the increase in HRP transport we observed after injection of 0.0001 mg LPS/kg, as well as the increase in HRP accumulation 24 hours before the increased endothelial cell death observed at higher LPS doses.
In this study, we have demonstrated that LPS injection changed both intimal and medial aortic HRP accumulation in vivo. Both increases preceded significant LPS-induced endothelial cell death and proliferation, indicating that LPS may cause increased endothelial cell permeability, possibly through TNFmediated cytoskeletal changes. The differences between the time courses of intimal and medial HRP accumulation can be explained by the IEL acting as a major barrier to protein entry into the media and by LPS altering transiently the barrier function of the IEL. We demonstrated that the increase in medial accumulation is driven by an increase in transmural convective transport and that the IEL is the ratelimiting barrier to convective transport across the arterial wall during LPS injury. These data suggest that the IEL is a significant barrier both to macromolecular entry and to transmural convective transport even in the normal artery. Finally, our data are consistent with both the endothelial cell layer and the internal elastic lamina acting to determine intimal macromolecular concentrations as hypothesized by Fry.1 This may explain how macromolecules (e.g., low density lipoproteins) that enter the intima due to a breach in the barrier function of the endothelium could become trapped, resulting in intimal concentrations greater than those in plasma.26 Such a view is consistent with the response to injury hypothesis proposed by Ross3 and may help to explain why atherosclerosis begins as an intimal disease.
